Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe, North America and Oceania. The aim of this trial is to
evaluate the haemostatic efficacy of activated recombinant human factor VII in subjects
undergoing orthotopic liver transplantation surgery.